 neurolept malign syndrom parkinson diseas withdraw alter dopaminerg therapi neurolept malign syndrom alter conscious fever extrapyramid sign autonom instabl creatin kinas level leukocytosi patient neurolept drug syndrom patient parkinson diseas withdraw reduct levodopa therapi dopaminerg drug therapi case neurolept malign syndrom withdraw levodopa therapi case varieti circumst alter therapi dopaminerg drug syndrom rel unfamiliar neurolept malign syndrome-levodopa relationship physician larg number patient parkinson diseas understand role brain dopamin pathogenesi neurolept malign syndrom appreci great varieti drug manipul fatal syndrom proper time recognit pharmacolog manipul neurolept drug